Monopar Therapeutics (1IY0.F) Q2 2026 Earnings

14MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.58
-0.48
-0.39
-0.3

Details

Expected EPS
-0.5773589726
Actual EPS
-0.394358
Surprise EPS
0.18
Surprise Percent
+31.7%

Description

Monopar Therapeutics (1IY0.F) has reported earnings of -0.394358 per share for Q2 2026.

0 Comments

Share your thoughts